The World Health Organization (WHO) has announced the end of the COVID-19 public health emergency (PHE). The move comes after reported deaths and hospitalizations for the disease have plummeted in recent months. PHE status as declared by the WHO won’t immediately rescind healthcare policy changes in all nations, but countries are already set to end their own PHEs, triggering massive changes to Medicare enrollment in the US.
The World Health Organization (WHO) has conditionally recommended Gilead’s COVID-19 antiviral Remsdesivir (Veklury), which was already conditionally recommended for non-severe COVID-19. The recommendation was made on positive results from the organization’s SOLIDARITY, which found that patients had a 13% decrease to relative risk of mortality in severe COVID-19 patients.